Bioinformatics (Oxford, England) · 2026
CSGDA: A Cell State-Guided Graph Domain Adaptation Network for Single-Cell Drug Response Prediction.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yan Fen, Xie Donggui, Cao Xiyue, Mao Feiqiao, You Zhuhong, Chen Yitao, Du Zhihua, Huang Yu-An
Аннотация
MOTIVATION: Intratumoral heterogeneity drives cancer recurrence and metastasis, yet single-cell drug response prediction faces severe "cross-domain" challenges, such as applying in vitro models to in vivo tissues or inferring metastatic resistance from primary tumors. These scenarios trigger distribution shifts arising from heterogeneous sequencing platforms, distinct tissue microenvironments, and metastatic evolution-problems rarely addressed by existing methods.
RESULTS: We introduce CSGDA, a cell state-guided graph domain adaptation framework designed to predict drug responses across these biological heterogeneities. CSGDA incorporates biological priors to map gene expression into functional cell states, guiding a structure learning module to construct robust cell topology. To mitigate distribution shifts, the model employs graph domain adaptation combined with a novel overlap penalty mechanism. Extensive benchmarks on five scRNA-seq datasets demonstrate that CSGDA outperforms the state-of-the-art method SSDA4Drug by approximately 6 percentage points in both ACC and AUPR. Beyond prediction accuracy, we employed integrated gradients to effectively pinpoint key genes involved in drug resistance within a challenging cross-metastasis cisplatin dataset. These findings underscore CSGDA's superior performance in single-cell drug response prediction and its potential in resolving single-cell heterogeneity, paving the way for precision medicine.
AVAILABILITY AND IMPLEMENTATION: Source code is available at https://github.com/yanfen-git/CSGDA-code and archived at https://doi.org/10.5281/zenodo.21759274. Data are available at https://doi.org/10.5281/zenodo.21770737.
SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
RESULTS: We introduce CSGDA, a cell state-guided graph domain adaptation framework designed to predict drug responses across these biological heterogeneities. CSGDA incorporates biological priors to map gene expression into functional cell states, guiding a structure learning module to construct robust cell topology. To mitigate distribution shifts, the model employs graph domain adaptation combined with a novel overlap penalty mechanism. Extensive benchmarks on five scRNA-seq datasets demonstrate that CSGDA outperforms the state-of-the-art method SSDA4Drug by approximately 6 percentage points in both ACC and AUPR. Beyond prediction accuracy, we employed integrated gradients to effectively pinpoint key genes involved in drug resistance within a challenging cross-metastasis cisplatin dataset. These findings underscore CSGDA's superior performance in single-cell drug response prediction and its potential in resolving single-cell heterogeneity, paving the way for precision medicine.
AVAILABILITY AND IMPLEMENTATION: Source code is available at https://github.com/yanfen-git/CSGDA-code and archived at https://doi.org/10.5281/zenodo.21759274. Data are available at https://doi.org/10.5281/zenodo.21770737.
SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.